First Header Logo Second Header Logo

Connection

Anthony Atala to Male

This is a "connection" page, showing publications Anthony Atala has written about Male.
Connection Strength

6.735
  1. Magalhaes RS, Williams JK, Yoo KW, Yoo JJ, Atala A. A tissue-engineered uterus supports live births in rabbits. Nat Biotechnol. 2020 11; 38(11):1280-1287.
    View in: PubMed
    Score: 0.056
  2. Jorgensen AM, Varkey M, Gorkun A, Clouse C, Xu L, Chou Z, Murphy SV, Molnar J, Lee SJ, Yoo JJ, Soker S, Atala A. Bioprinted Skin Recapitulates Normal Collagen Remodeling in Full-Thickness Wounds. Tissue Eng Part A. 2020 05; 26(9-10):512-526.
    View in: PubMed
    Score: 0.054
  3. Zhang C, George SK, Wu R, Thakker PU, Abolbashari M, Kim TH, Ko IK, Zhang Y, Sun Y, Jackson J, Lee SJ, Yoo JJ, Atala A. Reno-protection of Urine-derived Stem Cells in A Chronic Kidney Disease Rat Model Induced by Renal Ischemia and Nephrotoxicity. Int J Biol Sci. 2020; 16(3):435-446.
    View in: PubMed
    Score: 0.054
  4. Atala A. Re: ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer. J Urol. 2019 11; 202(5):869-870.
    View in: PubMed
    Score: 0.053
  5. Atala A. Re: The Proteogenomic Landscape of Curable Prostate Cancer. J Urol. 2019 10; 202(4):664.
    View in: PubMed
    Score: 0.053
  6. Atala A. Re: Hydroxysteroid (17ß) Dehydrogenase 1 Expressed by Sertoli Cells Contributes to Steroid Synthesis and is Required for Male Fertility. J Urol. 2019 09; 202(3):461-462.
    View in: PubMed
    Score: 0.052
  7. Atala A. Re: Inhibition of De Novo Lipogenesis Targets Androgen Receptor Signaling in Castration-Resistant Prostate Cancer. J Urol. 2019 09; 202(3):460-461.
    View in: PubMed
    Score: 0.052
  8. Atala A. Re: Inhibition of De Novo Lipogenesis Targets Androgen Receptor Signaling in Castration-Resistant Prostate Cancer. J Urol. 2019 08; 202(2):214.
    View in: PubMed
    Score: 0.052
  9. Atala A. Re: Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories. J Urol. 2019 08; 202(2):213-214.
    View in: PubMed
    Score: 0.052
  10. Atala A. Re: Targeting FOXA1-Mediated Repression of TGF-ß Signaling Suppresses Castration-Resistant Prostate Cancer Progression. J Urol. 2019 07; 202(1):36.
    View in: PubMed
    Score: 0.052
  11. Atala A. Re: Alterations of Tumor Microenvironment by Nitric Oxide Impedes Castration-Resistant Prostate Cancer Growth. J Urol. 2019 07; 202(1):35-36.
    View in: PubMed
    Score: 0.052
  12. Atala A. Re: Genetic Variation in the SIM1 Locus is Associated with Erectile Dysfunction. J Urol. 2019 06; 201(6):1056.
    View in: PubMed
    Score: 0.052
  13. Ko IK, Yoo ES, Park SM, Lee BK, Kim JH, Yoo JJ, Atala A. Use of uniformly sized muscle fiber fragments for restoration of muscle tissue function. J Tissue Eng Regen Med. 2019 07; 13(7):1230-1240.
    View in: PubMed
    Score: 0.052
  14. Atala A. Re: Immunogenomic Analyses Associate Immunological Alterations with Mismatch Repair Defects in Prostate Cancer. J Urol. 2019 05; 201(5):861-862.
    View in: PubMed
    Score: 0.051
  15. Atala A. Re: Classification of Prostate Cancer Using a Protease Activity Nanosensor Library. J Urol. 2019 05; 201(5):862-863.
    View in: PubMed
    Score: 0.051
  16. Atala A. Re: Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import. J Urol. 2019 04; 201(4):668.
    View in: PubMed
    Score: 0.051
  17. Atala A. Re: Diverse AR-V7 Cistromes in Castration-Resistant Prostate Cancer are Governed by HoxB13. J Urol. 2019 03; 201(3):446-447.
    View in: PubMed
    Score: 0.051
  18. Atala A. Re: Large-Scale Transcriptome-Wide Association Study Identifies New Prostate Cancer Risk Regions. J Urol. 2019 03; 201(3):447.
    View in: PubMed
    Score: 0.051
  19. Atala A. Re: A Somatically Acquired Enhancer of the Androgen Receptor is a Noncoding Driver in Advanced Prostate Cancer. J Urol. 2019 02; 201(2):230.
    View in: PubMed
    Score: 0.050
  20. Atala A. Re: TRAF4-Mediated Ubiquitination of NGF Receptor TrkA Regulates Prostate Cancer Metastasis. J Urol. 2019 02; 201(2):230.
    View in: PubMed
    Score: 0.050
  21. Atala A. Re: Acquisition of Tumorigenic Potential and Therapeutic Resistance in CD133+ Subpopulation of Prostate Cancer Cells Exhibiting Stem-Cell Like Characteristics. J Urol. 2019 01; 201(1):33.
    View in: PubMed
    Score: 0.050
  22. Atala A. Re: Diverse AR-V7 Cistromes in Castration-Resistant Prostate Cancer are Governed by HoxB13. J Urol. 2019 01; 201(1):33-34.
    View in: PubMed
    Score: 0.050
  23. Atala A. Re: Sim1 Neurons are Sufficient for MC4R-Mediated Sexual Function in Male Mice. J Urol. 2018 11; 200(5):948.
    View in: PubMed
    Score: 0.049
  24. Atala A. Re: Compartmentalized Activities of the Pyruvate Dehydrogenase Complex Sustain Lipogenesis in Prostate Cancer. J Urol. 2018 10; 200(4):701-702.
    View in: PubMed
    Score: 0.049
  25. Atala A. Re: An Aberrant SREBP-Dependent Lipogenic Program Promotes Metastatic Prostate Cancer. J Urol. 2018 09; 200(3):501-502.
    View in: PubMed
    Score: 0.048
  26. Matz EL, Terlecki R, Zhang Y, Jackson J, Atala A. Stem Cell Therapy for Erectile Dysfunction. Sex Med Rev. 2019 Apr; 7(2):321-328.
    View in: PubMed
    Score: 0.048
  27. Atala A. Re: Vitamin D3 Prevents Calcium-Induced Progression of Early-Stage Prostate Tumors by Counteracting TRPC6 and Calcium Sensing Receptor Upregulation. J Urol. 2018 05; 199(5):1115-1116.
    View in: PubMed
    Score: 0.047
  28. Atala A. Re: Prostate Cancer-Associated SPOP Mutations Confer Resistance to BET Inhibitors through Stabilization of BRD4. J Urol. 2018 04; 199(4):895-896.
    View in: PubMed
    Score: 0.047
  29. Atala A. Re: Estrogen Receptor ß, a Regulator of Androgen Receptor Signaling in the Mouse Ventral Prostate. J Urol. 2018 01; 199(1):30-31.
    View in: PubMed
    Score: 0.046
  30. Murphy SV, Skardal A, Song L, Sutton K, Haug R, Mack DL, Jackson J, Soker S, Atala A. Solubilized Amnion Membrane Hyaluronic Acid Hydrogel Accelerates Full-Thickness Wound Healing. Stem Cells Transl Med. 2017 11; 6(11):2020-2032.
    View in: PubMed
    Score: 0.046
  31. Atala A. Re: The Metabolic Co-Regulator PGC1a Suppresses Prostate Cancer Metastasis. J Urol. 2017 12; 198(6):1212-1214.
    View in: PubMed
    Score: 0.046
  32. Atala A. Re: Genomic Hallmarks of Localized, Non-Indolent Prostate Cancer. J Urol. 2017 12; 198(6):1213.
    View in: PubMed
    Score: 0.046
  33. Atala A. Re: Smooth Muscle Progenitor Cells Derived from Human Pluripotent Stem Cells Induce Histologic Changes in Injured Urethral Sphincter. J Urol. 2017 12; 198(6):1214.
    View in: PubMed
    Score: 0.046
  34. Atala A. Re: Antagonists of Growth Hormone-Releasing Hormone Inhibit Proliferation Induced by Inflammation in Prostatic Epithelial Cells. J Urol. 2017 10; 198(4):747-748.
    View in: PubMed
    Score: 0.045
  35. Atala A. Re: Genome-Wide Association Study of Prostate-Specific Antigen Levels Identifies Novel Loci Independent of Prostate Cancer. J Urol. 2017 10; 198(4):747.
    View in: PubMed
    Score: 0.045
  36. Atala A. Re: AKT-Mediated Stabilization of Histone Methyltransferase WHSC1 Promotes Prostate Cancer Metastasis. J Urol. 2017 09; 198(3):485-487.
    View in: PubMed
    Score: 0.045
  37. Atala A. Re: MicroRNA-141 Suppresses Prostate Cancer Stem Cells and Metastasis by Targeting a Cohort of Pro-Metastasis Genes. J Urol. 2017 09; 198(3):486.
    View in: PubMed
    Score: 0.045
  38. Atala A. Re: SOX2 Promotes Lineage Plasticity and Antiandrogen Resistance in TP53- and RB1-Deficient Prostate Cancer. J Urol. 2017 08; 198(2):259.
    View in: PubMed
    Score: 0.045
  39. Atala A. Re: Rb1 and Trp53 Cooperate to Suppress Prostate Cancer Lineage Plasticity, Metastasis, and Antiandrogen Resistance. J Urol. 2017 07; 198(1):102-104.
    View in: PubMed
    Score: 0.045
  40. Atala A. Re: Low CD38 Identifies Progenitor-Like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome. J Urol. 2017 07; 198(1):103.
    View in: PubMed
    Score: 0.045
  41. Atala A. Re: Activation of Notch1 Synergizes with Multiple Pathways in Promoting Castration-Resistant Prostate Cancer. J Urol. 2017 06; 197(6):1458-1459.
    View in: PubMed
    Score: 0.044
  42. Atala A. Re: Androgen Receptor Antagonists Compromise T Cell Response against Prostate Cancer Leading to Early Tumor Relapse. J Urol. 2017 06; 197(6):1459.
    View in: PubMed
    Score: 0.044
  43. Atala A. Urological Tissue Cultures. J Urol. 2017 02; 197(2S):S15-S16.
    View in: PubMed
    Score: 0.044
  44. Atala A. Re: Activation of Notch1 Synergizes with Multiple Pathways in Promoting Castration-Resistant Prostate Cancer. J Urol. 2017 03; 197(3 Pt 1):700-702.
    View in: PubMed
    Score: 0.044
  45. Atala A. Re: Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome. J Urol. 2017 03; 197(3 Pt 1):701-702.
    View in: PubMed
    Score: 0.044
  46. Atala A. Re: Integrative Analyses Reveal a Long Noncoding RNA-Mediated Sponge Regulatory Network in Prostate Cancer. J Urol. 2017 03; 197(3 Pt 1):701.
    View in: PubMed
    Score: 0.044
  47. Atala A. Re: The Metabolic Co-Regulator PGC1a Suppresses Prostate Cancer Metastasis. J Urol. 2017 02; 197(2):402-403.
    View in: PubMed
    Score: 0.043
  48. Atala A. Re: Inhibition of the Hexosamine Biosynthetic Pathway Promotes Castration-Resistant Prostate Cancer. J Urol. 2017 02; 197(2):403.
    View in: PubMed
    Score: 0.043
  49. Atala A. Re: Treatment of Diabetes Mellitus-Induced Erectile Dysfunction Using Endothelial Progenitor Cells Genetically Modified with Human Telomerase Reverse Transcriptase. J Urol. 2017 02; 197(2):494.
    View in: PubMed
    Score: 0.043
  50. Atala A. Re: Resistance to Docetaxel in Prostate Cancer is Associated with Androgen Receptor Activation and Loss of KDM5D Expression. J Urol. 2017 01; 197(1):154-155.
    View in: PubMed
    Score: 0.043
  51. Atala A. Re: Genome Engineering Uncovers 54 Evolutionarily Conserved and Testis-Enriched Genes That are Not Required for Male Fertility in Mice. J Urol. 2016 12; 196(6):1817.
    View in: PubMed
    Score: 0.043
  52. Atala A. Re: Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-ß1. J Urol. 2016 12; 196(6):1817.
    View in: PubMed
    Score: 0.043
  53. Atala A. Re: N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells. J Urol. 2016 11; 196(5):1584-1585.
    View in: PubMed
    Score: 0.043
  54. Atala A. Re: Mammalian Elongation Factor 4 Regulates Mitochondrial Translation Essential for Spermatogenesis. J Urol. 2016 11; 196(5):1585.
    View in: PubMed
    Score: 0.043
  55. Atala A. Re: Two Genes Substitute for the Mouse Y Chromosome for Spermatogenesis and Reproduction. J Urol. 2016 09; 196(3):957-8.
    View in: PubMed
    Score: 0.042
  56. Atala A. Re: Bone Metastasis in Prostate Cancer: Recurring Mitochondrial DNA Mutation Reveals Selective Pressure Exerted by the Bone Microenvironment. J Urol. 2016 09; 196(3):957-8.
    View in: PubMed
    Score: 0.042
  57. Atala A. Re: Dietary Flavonoid Fisetin Binds to ß-Tubulin and Disrupts Microtubule Dynamics in Prostate Cancer Cells. J Urol. 2016 08; 196(2):618.
    View in: PubMed
    Score: 0.042
  58. Atala A. Re: Autophagy Defects Suggested by Low Levels of Autophagy Activator MAP1S and High Levels of Autophagy Inhibitor LRPPRC Predict Poor Prognosis of Prostate Cancer Patients. J Urol. 2016 06; 195(6):1948-9.
    View in: PubMed
    Score: 0.041
  59. Sadri-Ardekani H, McLean TW, Kogan S, Sirintrapun J, Crowell K, Yousif MQ, Hodges SJ, Petty J, Pranikoff T, Sieren L, Zeller K, Atala A. Experimental testicular tissue banking to generate spermatogenesis in the future: A multidisciplinary team approach. Methods. 2016 Apr 15; 99:120-7.
    View in: PubMed
    Score: 0.041
  60. Atala A. Re: RNA-Seq of Single Prostate CTCs Implicates Noncanonical Wnt Signaling in Antiandrogen Resistance. J Urol. 2016 May; 195(5):1621-1622.
    View in: PubMed
    Score: 0.041
  61. Atala A. Re: AKAP3 Degradation in Sperm Capacitation is Regulated by its Tyrosine Phosphorylation. J Urol. 2016 May; 195(5):1622.
    View in: PubMed
    Score: 0.041
  62. Sunwook K, Nussbaum MA, Quandt SA, Laurienti PJ, Arcury TA. Effects of Lifetime Occupational Pesticide Exposure on Postural Control Among Farmworkers and Non-Farmworkers. J Occup Environ Med. 2016 Feb; 58(2):133-9.
    View in: PubMed
    Score: 0.041
  63. Sunwook K, Nussbaum MA, Quandt SA, Laurienti PJ, Arcury TA. Effects of Lifetime Occupational Pesticide Exposure on Postural Control Among Farmworkers and Non-Farmworkers. J Occup Environ Med. 2016 Feb; 58(2):133-9.
    View in: PubMed
    Score: 0.041
  64. Sunwook K, Nussbaum MA, Quandt SA, Laurienti PJ, Arcury TA. Effects of Lifetime Occupational Pesticide Exposure on Postural Control Among Farmworkers and Non-Farmworkers. J Occup Environ Med. 2016 Feb; 58(2):133-9.
    View in: PubMed
    Score: 0.041
  65. Atala A. Re: Sex Hormone-Dependent tRNA Halves Enhance Cell Proliferation in Breast and Prostate Cancers. J Urol. 2016 04; 195(4 Pt 1):1168-9.
    View in: PubMed
    Score: 0.041
  66. Atala A. Re: Expression of Nuclear Matrix Proteins Binding Matrix Attachment Regions in Prostate Cancer. PARP-1: New Player in Tumor Progression. J Urol. 2016 Mar; 195(3):801.
    View in: PubMed
    Score: 0.041
  67. Atala A. Re: Prostate Sphere-Forming Stem Cells are Derived from the P63-Expressing Basal Compartment. J Urol. 2016 Mar; 195(3):801-2.
    View in: PubMed
    Score: 0.041
  68. Atala A. Re: Peroxiredoxin 4: A Novel Secreted Mediator of Cancer Induced Osteoclastogenesis. J Urol. 2016 Jan; 195(1):220-1.
    View in: PubMed
    Score: 0.040
  69. Atala A. Re: Elf5 Inhibits TGF-ß-Driven Epithelial-Mesenchymal Transition in Prostate Cancer by Repressing SMAD3 Activation. J Urol. 2016 Jan; 195(1):221.
    View in: PubMed
    Score: 0.040
  70. Atala A. Re: PLCe Knockdown Inhibits Prostate Cancer Cell Proliferation via Suppression of Notch Signalling and Nuclear Translocation of the Androgen Receptor. J Urol. 2016 Feb; 195(2):524-5.
    View in: PubMed
    Score: 0.040
  71. Atala A. Re: Regulation of the ITGA2 Gene by Epigenetic Mechanisms in Prostate Cancer. J Urol. 2016 Feb; 195(2):525.
    View in: PubMed
    Score: 0.040
  72. Atala A. Re: Brain Feminization Requires Active Repression of Masculinization via DNA Methylation. J Urol. 2015 Dec; 194(6):1823.
    View in: PubMed
    Score: 0.040
  73. Atala A. Re: A Feedback Regulation between miR-145 and DNA Methyltransferase 3b in Prostate Cancer Cell and Their Responses to Irradiation. J Urol. 2015 Dec; 194(6):1823-4.
    View in: PubMed
    Score: 0.040
  74. Atala A. Re: Bone Marrow-Derived Cells Contribute to Regeneration of Injured Prostate Epithelium and Stroma. J Urol. 2015 Dec; 194(6):1824.
    View in: PubMed
    Score: 0.040
  75. Atala A. Re: Imbalanced Lipid Homeostasis in the Conditional Dicer1 Knockout Mouse Epididymis Causes Instability of the Sperm Membrane. J Urol. 2015 Oct; 194(4):1162-3.
    View in: PubMed
    Score: 0.039
  76. Atala A. Re: Loss of Expression of the Tumour Suppressor Gene AIMP3 Predicts Survival following Radiotherapy in Muscle-Invasive Bladder Cancer. J Urol. 2015 Oct; 194(4):1162-3.
    View in: PubMed
    Score: 0.039
  77. Atala A. Re: The Inhibitor of Differentiation Isoform Id1b, Generated by Alternative Splicing, Maintains Cell Quiescence and Confers Self-Renewal and Cancer Stem Cell-Like Properties. J Urol. 2015 Oct; 194(4):1163.
    View in: PubMed
    Score: 0.039
  78. Atala A. Re: SAHA Triggered MET Activation Contributes to SAHA Tolerance in Solid Cancer Cells. J Urol. 2015 Sep; 194(3):848-9.
    View in: PubMed
    Score: 0.039
  79. Atala A. Re: A Human Prostatic Bacterial Isolate Alters the Prostatic Microenvironment and Accelerates Prostate Cancer Progression. J Urol. 2015 Sep; 194(3):849.
    View in: PubMed
    Score: 0.039
  80. Atala A. Re: Circulating Biomarkers of One-Carbon Metabolism in Relation to Renal Cell Carcinoma Incidence and Survival. J Urol. 2015 Aug; 194(2):593-4.
    View in: PubMed
    Score: 0.039
  81. Atala A. Re: Ion Channel TRPM8 Promotes Hypoxic Growth of Prostate Cancer Cells via an O2-Independent and RACK1-Mediated Mechanism of HIF-1a Stabilization. J Urol. 2015 Jul; 194(1):260.
    View in: PubMed
    Score: 0.039
  82. Atala A. Re: Bone-Induced c-Kit Expression in Prostate Cancer: A Driver of Intraosseous Tumor Growth. J Urol. 2015 Jul; 194(1):260.
    View in: PubMed
    Score: 0.039
  83. Atala A. Re: Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer. J Urol. 2015 Jun; 193(6):2146-7.
    View in: PubMed
    Score: 0.039
  84. Atala A. Re: Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer. J Urol. 2015 Jun; 193(6):2146.
    View in: PubMed
    Score: 0.039
  85. Atala A. Re: Identification and characterization of membrane androgen receptors in the ZIP9 zinc transporter subfamily: II. Role of human ZIP9 in testosterone-induced prostate and breast cancer cell apoptosis. J Urol. 2015 Jun; 193(6):2147.
    View in: PubMed
    Score: 0.039
  86. Atala A. Re: Estrogen receptor ß upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer. J Urol. 2015 May; 193(5):1725.
    View in: PubMed
    Score: 0.038
  87. Atala A. Re: Adipose tissue-derived stem cells suppress acute cellular rejection by TSG-6 and CD44 interaction in rat kidney transplantation. J Urol. 2015 Apr; 193(4):1441.
    View in: PubMed
    Score: 0.038
  88. Atala A. Re: Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy. J Urol. 2015 Apr; 193(4):1441-2.
    View in: PubMed
    Score: 0.038
  89. Atala A. Re: Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer. J Urol. 2015 Apr; 193(4):1442.
    View in: PubMed
    Score: 0.038
  90. Atala A. Re: Characteristics of TRK-130 (naltalimide), a novel opioid ligand, as a new therapeutic agent for overactive bladder. J Urol. 2015 Mar; 193(3):1060.
    View in: PubMed
    Score: 0.038
  91. Atala A. Re: Intravesical TRPV4 blockade reduces repeated variate stress-induced bladder dysfunction by increasing bladder capacity and decreasing voiding frequency in male rats. J Urol. 2015 Mar; 193(3):1060-1.
    View in: PubMed
    Score: 0.038
  92. Atala A. Re: Mutations in 3'-long terminal repeat of HERV-W family in chromosome 7 upregulate syncytin-1 expression in urothelial cell carcinoma of the bladder through interacting with c-Myb. J Urol. 2015 Mar; 193(3):1061.
    View in: PubMed
    Score: 0.038
  93. Moradi M, Hood B, Moradi M, Atala A. The potential role of regenerative medicine in the man-agement of traumatic patients. J Inj Violence Res. 2015 Jan; 7(1):27-35.
    View in: PubMed
    Score: 0.038
  94. Atala A. Re: Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer. J Urol. 2015 Jan; 193(1):368.
    View in: PubMed
    Score: 0.037
  95. Atala A. Re: Neurosensory perception of environmental cues modulates sperm motility critical for fertilization. J Urol. 2015 Jan; 193(1):368-9.
    View in: PubMed
    Score: 0.037
  96. Atala A. Re: Lack of testicular seipin causes teratozoospermia syndrome in men. J Urol. 2015 Jan; 193(1):369.
    View in: PubMed
    Score: 0.037
  97. Atala A. Human stem cell-derived retinal cells for macular diseases. Lancet. 2015 Feb 07; 385(9967):487-8.
    View in: PubMed
    Score: 0.037
  98. Sadri-Ardekani H, Atala A. Testicular tissue cryopreservation and spermatogonial stem cell transplantation to restore fertility: from bench to bedside. Stem Cell Res Ther. 2014 May 28; 5(3):68.
    View in: PubMed
    Score: 0.036
  99. Atala A. Re: The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. J Urol. 2014 Aug; 192(2):613.
    View in: PubMed
    Score: 0.036
  100. Atala A. Re: Dietary sources of N-nitroso compounds and bladder cancer risk: findings from the Los Angeles Bladder Cancer Study. J Urol. 2014 Aug; 192(2):614-5.
    View in: PubMed
    Score: 0.036
  101. Atala A. Re: Carvedilol efficiently protects kidneys without affecting the antitumor efficacy of cisplatin in mice. J Urol. 2014 Aug; 192(2):614.
    View in: PubMed
    Score: 0.036
  102. Atala A. Re: TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer. J Urol. 2014 Jun; 191(6):1927.
    View in: PubMed
    Score: 0.036
  103. Atala A. Re: bispecific small molecule-antibody conjugate targeting prostate cancer. J Urol. 2014 Jun; 191(6):1927-8.
    View in: PubMed
    Score: 0.036
  104. Atala A. Re: leptin signaling in GABA neurons, but not glutamate neurons, is required for reproductive function. J Urol. 2014 Jun; 191(6):1928.
    View in: PubMed
    Score: 0.036
  105. Atala A. Regenerative bladder augmentation using autologous tissue-when will we get there? J Urol. 2014 May; 191(5):1204-5.
    View in: PubMed
    Score: 0.036
  106. Atala A. Re: lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. J Urol. 2014 May; 191(5):1470-1.
    View in: PubMed
    Score: 0.036
  107. Atala A. Re: basigin null mutant male mice are sterile and exhibit impaired interactions between germ cells and Sertoli cells. J Urol. 2014 May; 191(5):1471.
    View in: PubMed
    Score: 0.036
  108. Orabi H, Aboushwareb T, Tan J, Yoo JJ, Atala A. Can computed tomography--assisted virtual endoscopy be an innovative tool for detecting urethral tissue pathologies? Urology. 2014 Apr; 83(4):930-8.
    View in: PubMed
    Score: 0.036
  109. Atala A. Re: Gene signatures distinguish stage-specific prostate cancer stem cells isolated from transgenic adenocarcinoma of the mouse prostate lesions and predict the malignancy of human tumors. J Urol. 2014 Apr; 191(4):1181.
    View in: PubMed
    Score: 0.036
  110. Atala A. Re: Differential stage-dependent regulation of prostatic epithelial morphogenesis by Hedgehog signaling. J Urol. 2014 Apr; 191(4):1181-2.
    View in: PubMed
    Score: 0.036
  111. Atala A. Re: miR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells. J Urol. 2014 Apr; 191(4):1182.
    View in: PubMed
    Score: 0.036
  112. Atala A. Re: antitumoral effects of vasoactive intestinal peptide in human renal cell carcinoma xenografts in athymic nude mice. J Urol. 2014 Mar; 191(3):866-8.
    View in: PubMed
    Score: 0.035
  113. Atala A. Re: enhanced therapeutic effect of cisplatin on the prostate cancer in tumor-bearing mice by transfecting the attenuated salmonella carrying a plasmid co-expressing p53 gene and MDM2 siRNA. J Urol. 2014 Mar; 191(3):866-7.
    View in: PubMed
    Score: 0.035
  114. Atala A. Re: telomere length influences cancer cell differentiation in vivo. J Urol. 2014 Mar; 191(3):867-8.
    View in: PubMed
    Score: 0.035
  115. Atala A. Re: missense mutations in SLC26A8, encoding a sperm-specific activator of CFTR, are associated with human asthenozoospermia. J Urol. 2014 Feb; 191(2):554-5.
    View in: PubMed
    Score: 0.035
  116. Atala A. Re: decreased androgen receptor expression may contribute to spermatogenesis failure in rats exposed to low concentration of bisphenol A. J Urol. 2014 Feb; 191(2):554.
    View in: PubMed
    Score: 0.035
  117. Atala A. Re: CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer. J Urol. 2014 Jan; 191(1):270-1.
    View in: PubMed
    Score: 0.035
  118. Atala A. Re: Loss of ß1-integrin from urothelium results in overactive bladder and incontinence in mice: a mechanosensory rather than structural phenotype. J Urol. 2013 Dec; 190(6):2305.
    View in: PubMed
    Score: 0.035
  119. Atala A. Re: Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. J Urol. 2013 Dec; 190(6):2306.
    View in: PubMed
    Score: 0.035
  120. Atala A. Re: PRC1 coordinates timing of sexual differentiation of female primordial germ cells. J Urol. 2013 Nov; 190(5):1954-5.
    View in: PubMed
    Score: 0.034
  121. Atala A. Re: Aire-dependent thymic development of tumor-associated regulatory T cells. J Urol. 2013 Nov; 190(5):1954.
    View in: PubMed
    Score: 0.034
  122. Atala A. Re: Down-regulation of CatSper1 channel in epididymal spermatozoa contributes to the pathogenesis of asthenozoospermia, whereas up-regulation of the Channel by Sheng-Jing-San treatment improves the sperm motility of asthenozoospermia in rats. J Urol. 2013 Oct; 190(4):1436-7.
    View in: PubMed
    Score: 0.034
  123. Atala A. Re: Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer. J Urol. 2013 Oct; 190(4):1437.
    View in: PubMed
    Score: 0.034
  124. Atala A. Re: Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist. J Urol. 2013 Oct; 190(4):1436.
    View in: PubMed
    Score: 0.034
  125. Atala A. Re: p21-activated kinase 6 (PAK6) inhibits prostate cancer growth via phosphorylation of androgen receptor and tumorigenic E3 ligase murine double minute-2 (Mdm2). J Urol. 2013 Sep; 190(3):1131.
    View in: PubMed
    Score: 0.034
  126. Atala A. Re: a new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat. J Urol. 2013 Aug; 190(2):807.
    View in: PubMed
    Score: 0.034
  127. De Filippo RE, Kornitzer BS, Yoo JJ, Atala A. Penile urethra replacement with autologous cell-seeded tubularized collagen matrices. J Tissue Eng Regen Med. 2015 Mar; 9(3):257-64.
    View in: PubMed
    Score: 0.033
  128. Orabi H, AbouShwareb T, Zhang Y, Yoo JJ, Atala A. Cell-seeded tubularized scaffolds for reconstruction of long urethral defects: a preclinical study. Eur Urol. 2013 Mar; 63(3):531-8.
    View in: PubMed
    Score: 0.032
  129. Atala A. Tissue engineering of reproductive tissues and organs. Fertil Steril. 2012 Jul; 98(1):21-9.
    View in: PubMed
    Score: 0.032
  130. Patel MN, Atala A. Tissue engineering of the penis. ScientificWorldJournal. 2011; 11:2567-78.
    View in: PubMed
    Score: 0.031
  131. Atala A. Re.: A novel imaging approach for early detection of prostate cancer based on endogenous zinc sensing. J Urol. 2011 May; 185(5):1976.
    View in: PubMed
    Score: 0.029
  132. Atala A. Re.: Nonsteroidal selective androgen receptor modulators enhance female sexual motivation. J Urol. 2011 May; 185(5):1976-7.
    View in: PubMed
    Score: 0.029
  133. Raya-Rivera A, Esquiliano DR, Yoo JJ, Lopez-Bayghen E, Soker S, Atala A. Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet. 2011 Apr 02; 377(9772):1175-82.
    View in: PubMed
    Score: 0.029
  134. Atala A. Re: eIF4E Phosphorylation Promotes Tumorigenesis and is Associated With Prostate Cancer Progression. J Urol. 2011 Apr; 185(4):1533.
    View in: PubMed
    Score: 0.029
  135. Atala A. Re: Fkbp52 regulates androgen receptor transactivation activity and male urethra morphogenesis. J Urol. 2011 Apr; 185(4):1533-4.
    View in: PubMed
    Score: 0.029
  136. Atala A. Re.: Early life inorganic lead exposure induces testicular teratoma and renal and urinary bladder preneoplasia in adult metallothionein-knockout mice but not in wild type mice. J Urol. 2011 May; 185(5):1975-6.
    View in: PubMed
    Score: 0.029
  137. Chen KL, Eberli D, Yoo JJ, Atala A. Bioengineered corporal tissue for structural and functional restoration of the penis. Proc Natl Acad Sci U S A. 2010 Feb 23; 107(8):3346-50.
    View in: PubMed
    Score: 0.027
  138. Hodges SJ, Patel B, McLorie G, Atala A. Posterior urethral valves. ScientificWorldJournal. 2009 Oct 14; 9:1119-26.
    View in: PubMed
    Score: 0.026
  139. Eberli D, Susaeta R, Yoo JJ, Atala A. A method to improve cellular content for corporal tissue engineering. Tissue Eng Part A. 2008 Oct; 14(10):1581-9.
    View in: PubMed
    Score: 0.025
  140. Zhang Y, McNeill E, Tian H, Soker S, Andersson KE, Yoo JJ, Atala A. Urine derived cells are a potential source for urological tissue reconstruction. J Urol. 2008 Nov; 180(5):2226-33.
    View in: PubMed
    Score: 0.025
  141. Dorin RP, Pohl HG, De Filippo RE, Yoo JJ, Atala A. Tubularized urethral replacement with unseeded matrices: what is the maximum distance for normal tissue regeneration? World J Urol. 2008 Aug; 26(4):323-6.
    View in: PubMed
    Score: 0.024
  142. Connolly SS, Yoo JJ, Abouheba M, Soker S, McDougal WS, Atala A. Cavernous nerve regeneration using acellular nerve grafts. World J Urol. 2008 Aug; 26(4):333-9.
    View in: PubMed
    Score: 0.024
  143. el-Kassaby A, AbouShwareb T, Atala A. Randomized comparative study between buccal mucosal and acellular bladder matrix grafts in complex anterior urethral strictures. J Urol. 2008 Apr; 179(4):1432-6.
    View in: PubMed
    Score: 0.024
  144. Hipp J, Andersson KE, Kwon TG, Kwak EK, Yoo J, Atala A. Microarray analysis of exstrophic human bladder smooth muscle. BJU Int. 2008 Jan; 101(1):100-5.
    View in: PubMed
    Score: 0.023
  145. Christ G, Andersson KE, Atala A. The future of bladder research: molecular profiling, new drug targets, gene therapy, and tissue engineering. Curr Urol Rep. 2007 Mar; 8(2):95-9.
    View in: PubMed
    Score: 0.022
  146. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet. 2006 Apr 15; 367(9518):1241-6.
    View in: PubMed
    Score: 0.021
  147. Atala A. Recent developments in tissue engineering and regenerative medicine. Curr Opin Pediatr. 2006 Apr; 18(2):167-71.
    View in: PubMed
    Score: 0.021
  148. Hodges SJ, Atala A. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Curr Urol Rep. 2006 Jan; 7(1):41-2.
    View in: PubMed
    Score: 0.020
  149. Bartsch G, Yoo JJ, De Coppi P, Siddiqui MM, Schuch G, Pohl HG, Fuhr J, Perin L, Soker S, Atala A. Propagation, expansion, and multilineage differentiation of human somatic stem cells from dermal progenitors. Stem Cells Dev. 2005 Jun; 14(3):337-48.
    View in: PubMed
    Score: 0.020
  150. Atala A. What's new in urology. J Am Coll Surg. 2004 Sep; 199(3):446-61.
    View in: PubMed
    Score: 0.019
  151. Paltiel HJ, Diamond DA, Zurakowski D, Drubach LA, Atala A. Endoscopic treatment of vesicoureteral reflux with autologous chondrocytes: postoperative sonographic features. Radiology. 2004 Aug; 232(2):390-7.
    View in: PubMed
    Score: 0.018
  152. Yiou R, Yoo JJ, Atala A. Restoration of functional motor units in a rat model of sphincter injury by muscle precursor cell autografts. Transplantation. 2003 Oct 15; 76(7):1053-60.
    View in: PubMed
    Score: 0.017
  153. Falke G, Yoo JJ, Kwon TG, Moreland R, Atala A. Formation of corporal tissue architecture in vivo using human cavernosal muscle and endothelial cells seeded on collagen matrices. Tissue Eng. 2003 Oct; 9(5):871-9.
    View in: PubMed
    Score: 0.017
  154. Godbey WT, Atala A. Directed apoptosis in Cox-2-overexpressing cancer cells through expression-targeted gene delivery. Gene Ther. 2003 Aug; 10(17):1519-27.
    View in: PubMed
    Score: 0.017
  155. Machluf M, Orsola A, Boorjian S, Kershen R, Atala A. Microencapsulation of Leydig cells: a system for testosterone supplementation. Endocrinology. 2003 Nov; 144(11):4975-9.
    View in: PubMed
    Score: 0.017
  156. Yiou R, Lefaucheur JP, Atala A. The regeneration process of the striated urethral sphincter involves activation of intrinsic satellite cells. Anat Embryol (Berl). 2003 May; 206(6):429-35.
    View in: PubMed
    Score: 0.017
  157. El-Kassaby AW, Retik AB, Yoo JJ, Atala A. Urethral stricture repair with an off-the-shelf collagen matrix. J Urol. 2003 Jan; 169(1):170-3; discussion 173.
    View in: PubMed
    Score: 0.017
  158. Atala A. Urethral mobilization and advancement for midshaft to distal hypospadias. J Urol. 2002 Oct; 168(4 Pt 2):1738-41; discussion 1741.
    View in: PubMed
    Score: 0.016
  159. Kwon TG, Yoo JJ, Atala A. Autologous penile corpora cavernosa replacement using tissue engineering techniques. J Urol. 2002 Oct; 168(4 Pt 2):1754-8.
    View in: PubMed
    Score: 0.016
  160. De Filippo RE, Yoo JJ, Atala A. Urethral replacement using cell seeded tubularized collagen matrices. J Urol. 2002 Oct; 168(4 Pt 2):1789-92; discussion 1792-3.
    View in: PubMed
    Score: 0.016
  161. Kim BS, Yoo JJ, Atala A. Engineering of human cartilage rods: potential application for penile prostheses. J Urol. 2002 Oct; 168(4 Pt 2):1794-7.
    View in: PubMed
    Score: 0.016
  162. Lai JY, Yoon CY, Yoo JJ, Wulf T, Atala A. Phenotypic and functional characterization of in vivo tissue engineered smooth muscle from normal and pathological bladders. J Urol. 2002 Oct; 168(4 Pt 2):1853-7; discussion 1858.
    View in: PubMed
    Score: 0.016
  163. Lin LF, Zhu G, Yoo JJ, Soker S, Sukhatme VP, Atala A. A system for the enhancement of adenovirus mediated gene transfer to uro-epithelium. J Urol. 2002 Aug; 168(2):813-8.
    View in: PubMed
    Score: 0.016
  164. Kershen RT, Yoo JJ, Moreland RB, Krane RJ, Atala A. Reconstitution of human corpus cavernosum smooth muscle in vitro and in vivo. Tissue Eng. 2002 Jul; 8(3):515-24.
    View in: PubMed
    Score: 0.016
  165. Cilento BG, Atala A. Proximal hypospadias. Urol Clin North Am. 2002 May; 29(2):311-28, vi.
    View in: PubMed
    Score: 0.016
  166. Retik AB, Atala A. Complications of hypospadias repair. Urol Clin North Am. 2002 May; 29(2):329-39.
    View in: PubMed
    Score: 0.016
  167. Paltiel HJ, Diamond DA, Di Canzio J, Zurakowski D, Borer JG, Atala A. Testicular volume: comparison of orchidometer and US measurements in dogs. Radiology. 2002 Jan; 222(1):114-9.
    View in: PubMed
    Score: 0.015
  168. Atala A. Tissue engineering approaches for genital reconstruction. Adv Exp Med Biol. 2002; 511:289-303.
    View in: PubMed
    Score: 0.015
  169. Kim JH, Kim I, Seol YJ, Ko IK, Yoo JJ, Atala A, Lee SJ. Neural cell integration into 3D bioprinted skeletal muscle constructs accelerates restoration of muscle function. Nat Commun. 2020 02 24; 11(1):1025.
    View in: PubMed
    Score: 0.014
  170. Liu G, Wu R, Yang B, Shi Y, Deng C, Atala A, Mou S, Criswell T, Zhang Y. A cocktail of growth factors released from a heparin hyaluronic-acid hydrogel promotes the myogenic potential of human urine-derived stem cells in vivo. Acta Biomater. 2020 04 15; 107:50-64.
    View in: PubMed
    Score: 0.014
  171. Gu X, Thakker PU, Matz EL, Terlecki RP, Marini FC, Allickson JG, Lue TF, Lin G, Atala A, Yoo JJ, Zhang Y, Jackson JD. Dynamic Changes in Erectile Function and Histological Architecture After Intracorporal Injection of Human Placental Stem Cells in a Pelvic Neurovascular Injury Rat Model. J Sex Med. 2020 03; 17(3):400-411.
    View in: PubMed
    Score: 0.014
  172. Deebel NA, Galdon G, Zarandi NP, Stogner-Underwood K, Howards S, Lovato J, Kogan S, Atala A, Lue Y, Sadri-Ardekani H. Age-related presence of spermatogonia in patients with Klinefelter syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2020 01 01; 26(1):58-72.
    View in: PubMed
    Score: 0.013
  173. Smith BT, Bittner SM, Watson E, Smoak MM, Diaz-Gomez L, Molina ER, Kim YS, Hudgins CD, Melchiorri AJ, Scott DW, Grande-Allen KJ, Yoo JJ, Atala A, Fisher JP, Mikos AG. Multimaterial Dual Gradient Three-Dimensional Printing for Osteogenic Differentiation and Spatial Segregation. Tissue Eng Part A. 2020 03; 26(5-6):239-252.
    View in: PubMed
    Score: 0.013
  174. George SK, Abolbashari M, Kim TH, Zhang C, Allickson J, Jackson JD, Lee SJ, Ko IK, Atala A, Yoo JJ. Effect of Human Amniotic Fluid Stem Cells on Kidney Function in a Model of Chronic Kidney Disease. Tissue Eng Part A. 2019 11; 25(21-22):1493-1503.
    View in: PubMed
    Score: 0.013
  175. Abdelaal O, Barber H, Atala A, Sadri-Ardekani H. Purging of malignant cell contamination prior to spermatogonia stem cell autotransplantation to preserve fertility: progress & prospects. Curr Opin Endocrinol Diabetes Obes. 2019 06; 26(3):166-174.
    View in: PubMed
    Score: 0.013
  176. Huling J, Min SI, Kim DS, Ko IK, Atala A, Yoo JJ. Kidney regeneration with biomimetic vascular scaffolds based on vascular corrosion casts. Acta Biomater. 2019 09 01; 95:328-336.
    View in: PubMed
    Score: 0.013
  177. Gu X, Shi H, Matz E, Zhong L, Long T, Clouse C, Li W, Chen D, Chung H, Murphy S, Yoo J, Lin G, Lue T, Atala A, Jackson J, Zhang Y. Long-term therapeutic effect of cell therapy on improvement in erectile function in a rat model with pelvic neurovascular injury. BJU Int. 2019 07; 124(1):145-154.
    View in: PubMed
    Score: 0.013
  178. Glybochko PV, Alyaev YG, Khokhlachev SB, Fiev DN, Shpot EV, Petrovsky NV, Zhang D, Proskura AV, Yurova M, Matz EL, Wang X, Atala A, Zhang Y, Butnaru DV. 3D reconstruction of CT scans aid in preoperative planning for sarcomatoid renal cancer: A case report and mini-review. J Xray Sci Technol. 2019; 27(2):389-395.
    View in: PubMed
    Score: 0.013
  179. Wan Q, Xiong G, Liu G, Shupe TD, Wei G, Zhang D, Liang D, Lu X, Atala A, Zhang Y. Urothelium with barrier function differentiated from human urine-derived stem cells for potential use in urinary tract reconstruction. Stem Cell Res Ther. 2018 11 08; 9(1):304.
    View in: PubMed
    Score: 0.012
  180. Liu G, Wu R, Yang B, Deng C, Lu X, Walker SJ, Ma PX, Mou S, Atala A, Zhang Y. Human Urine-Derived Stem Cell Differentiation to Endothelial Cells with Barrier Function and Nitric Oxide Production. Stem Cells Transl Med. 2018 09; 7(9):686-698.
    View in: PubMed
    Score: 0.012
  181. Strange DP, Zarandi NP, Trivedi G, Atala A, Bishop CE, Sadri-Ardekani H, Verma S. Human testicular organoid system as a novel tool to study Zika virus pathogenesis. Emerg Microbes Infect. 2018 05 09; 7(1):82.
    View in: PubMed
    Score: 0.012
  182. Peak TC, Praharaj PP, Panigrahi GK, Doyle M, Su Y, Schlaepfer IR, Singh R, Vander Griend DJ, Alickson J, Hemal A, Atala A, Deep G. Exosomes secreted by placental stem cells selectively inhibit growth of aggressive prostate cancer cells. Biochem Biophys Res Commun. 2018 05 23; 499(4):1004-1010.
    View in: PubMed
    Score: 0.012
  183. Pendergraft SS, Sadri-Ardekani H, Atala A, Bishop CE. Three-dimensional testicular organoid: a novel tool for the study of human spermatogenesis and gonadotoxicity in vitro. Biol Reprod. 2017 03 01; 96(3):720-732.
    View in: PubMed
    Score: 0.011
  184. Zhang K, Fu Q, Yoo J, Chen X, Chandra P, Mo X, Song L, Atala A, Zhao W. 3D bioprinting of urethra with PCL/PLCL blend and dual autologous cells in fibrin hydrogel: An in vitro evaluation of biomimetic mechanical property and cell growth environment. Acta Biomater. 2017 03 01; 50:154-164.
    View in: PubMed
    Score: 0.011
  185. Kim JH, Ko IK, Atala A, Yoo JJ. Progressive Muscle Cell Delivery as a Solution for Volumetric Muscle Defect Repair. Sci Rep. 2016 12 07; 6:38754.
    View in: PubMed
    Score: 0.011
  186. George SK, Abolbashari M, Jackson JD, Aboushwareb T, Atala A, Yoo JJ. Potential Use of Autologous Renal Cells from Diseased Kidneys for the Treatment of Renal Failure. PLoS One. 2016; 11(10):e0164997.
    View in: PubMed
    Score: 0.011
  187. Galdon G, Atala A, Sadri-Ardekani H. In Vitro Spermatogenesis: How Far from Clinical Application? Curr Urol Rep. 2016 Jul; 17(7):49.
    View in: PubMed
    Score: 0.011
  188. Kim N, Yoo JJ, Atala A, Lee SJ. Combination of small RNAs for skeletal muscle regeneration. FASEB J. 2016 Mar; 30(3):1198-206.
    View in: PubMed
    Score: 0.010
  189. Lv XG, Feng C, Fu Q, Xie H, Wang Y, Huang JW, Xie MK, Atala A, Xu YM, Zhao WX. Comparative study of different seeding methods based on a multilayer SIS scaffold: Which is the optimal procedure for urethral tissue engineering? . 2016 08; 104(6):1098-108.
    View in: PubMed
    Score: 0.010
  190. Lim HJ, Joo S, Oh SH, Jackson JD, Eckman DM, Bledsoe TM, Pierson CR, Childers MK, Atala A, Yoo JJ. Syngeneic Myoblast Transplantation Improves Muscle Function in a Murine Model of X-Linked Myotubular Myopathy. Cell Transplant. 2015; 24(9):1887-900.
    View in: PubMed
    Score: 0.009
  191. Chen W, Xie M, Yang B, Bharadwaj S, Song L, Liu G, Yi S, Ye G, Atala A, Zhang Y. Skeletal myogenic differentiation of human urine-derived cells as a potential source for skeletal muscle regeneration. J Tissue Eng Regen Med. 2017 02; 11(2):334-341.
    View in: PubMed
    Score: 0.009
  192. Hwang CM, Lee BK, Green D, Jeong SY, Khang G, Jackson JD, Atala A, Lee SJ, Yoo JJ. Auricular reconstruction using tissue-engineered alloplastic implants for improved clinical outcomes. Plast Reconstr Surg. 2014 Mar; 133(3):360e-369e.
    View in: PubMed
    Score: 0.009
  193. Chapple C, Andrich D, Atala A, Barbagli G, Cavalcanti A, Kulkarni S, Mangera A, Nakajima Y. SIU/ICUD Consultation on Urethral Strictures: The management of anterior urethral stricture disease using substitution urethroplasty. Urology. 2014 Mar; 83(3 Suppl):S31-47.
    View in: PubMed
    Score: 0.009
  194. Liu G, Sun X, Bian J, Wu R, Guan X, Ouyang B, Huang Y, Xiao H, Luo D, Atala A, Zhang Y, Deng C. Correction of diabetic erectile dysfunction with adipose derived stem cells modified with the vascular endothelial growth factor gene in a rodent diabetic model. PLoS One. 2013; 8(8):e72790.
    View in: PubMed
    Score: 0.009
  195. Liu G, Wang X, Sun X, Deng C, Atala A, Zhang Y. The effect of urine-derived stem cells expressing VEGF loaded in collagen hydrogels on myogenesis and innervation following after subcutaneous implantation in nude mice. Biomaterials. 2013 Nov; 34(34):8617-29.
    View in: PubMed
    Score: 0.009
  196. Ko IK, Lee BK, Lee SJ, Andersson KE, Atala A, Yoo JJ. The effect of in vitro formation of acetylcholine receptor (AChR) clusters in engineered muscle fibers on subsequent innervation of constructs in vivo. Biomaterials. 2013 Apr; 34(13):3246-55.
    View in: PubMed
    Score: 0.008
  197. Lang R, Liu G, Shi Y, Bharadwaj S, Leng X, Zhou X, Liu H, Atala A, Zhang Y. Self-renewal and differentiation capacity of urine-derived stem cells after urine preservation for 24 hours. PLoS One. 2013; 8(1):e53980.
    View in: PubMed
    Score: 0.008
  198. Kaushik SB, Kwatra SG, McLean TW, Powers A, Atala AJ, Yosipovitch G. Segmental ulcerated perineal hemangioma of infancy: a complex case of PELVIS syndrome successfully treated using a multidisciplinary approach. Pediatr Dermatol. 2013 Nov-Dec; 30(6):e257-8.
    View in: PubMed
    Score: 0.008
  199. Liu G, Pareta RA, Wu R, Shi Y, Zhou X, Liu H, Deng C, Sun X, Atala A, Opara EC, Zhang Y. Skeletal myogenic differentiation of urine-derived stem cells and angiogenesis using microbeads loaded with growth factors. Biomaterials. 2013 Jan; 34(4):1311-26.
    View in: PubMed
    Score: 0.008
  200. Wang HJ, Varner A, AbouShwareb T, Atala A, Yoo JJ. Ischemia/reperfusion-induced renal failure in rats as a model for evaluating cell therapies. Ren Fail. 2012; 34(10):1324-32.
    View in: PubMed
    Score: 0.008
  201. Lee BK, Ju YM, Cho JG, Jackson JD, Lee SJ, Atala A, Yoo JJ. End-to-side neurorrhaphy using an electrospun PCL/collagen nerve conduit for complex peripheral motor nerve regeneration. Biomaterials. 2012 Dec; 33(35):9027-36.
    View in: PubMed
    Score: 0.008
  202. Moschidou D, Mukherjee S, Blundell MP, Drews K, Jones GN, Abdulrazzak H, Nowakowska B, Phoolchund A, Lay K, Ramasamy TS, Cananzi M, Nettersheim D, Sullivan M, Frost J, Moore G, Vermeesch JR, Fisk NM, Thrasher AJ, Atala A, Adjaye J, Schorle H, De Coppi P, Guillot PV. Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther. 2012 Oct; 20(10):1953-67.
    View in: PubMed
    Score: 0.008
  203. Kang SB, Olson JL, Atala A, Yoo JJ. Functional recovery of completely denervated muscle: implications for innervation of tissue-engineered muscle. Tissue Eng Part A. 2012 Sep; 18(17-18):1912-20.
    View in: PubMed
    Score: 0.008
  204. Rodrigues MT, Lee BK, Lee SJ, Gomes ME, Reis RL, Atala A, Yoo JJ. The effect of differentiation stage of amniotic fluid stem cells on bone regeneration. Biomaterials. 2012 Sep; 33(26):6069-78.
    View in: PubMed
    Score: 0.008
  205. Yamaleyeva LM, Guimaraes-Souza NK, Krane LS, Agcaoili S, Gyabaah K, Atala A, Aboushwareb T, Yoo JJ. Cell therapy with human renal cell cultures containing erythropoietin-positive cells improves chronic kidney injury. Stem Cells Transl Med. 2012 May; 1(5):373-83.
    View in: PubMed
    Score: 0.008
  206. Guimaraes-Souza NK, Yamaleyeva LM, AbouShwareb T, Atala A, Yoo JJ. In vitro reconstitution of human kidney structures for renal cell therapy. Nephrol Dial Transplant. 2012 Aug; 27(8):3082-90.
    View in: PubMed
    Score: 0.008
  207. Ko IK, Ju YM, Chen T, Atala A, Yoo JJ, Lee SJ. Combined systemic and local delivery of stem cell inducing/recruiting factors for in situ tissue regeneration. FASEB J. 2012 Jan; 26(1):158-68.
    View in: PubMed
    Score: 0.008
  208. Bharadwaj S, Liu G, Shi Y, Markert C, Andersson KE, Atala A, Zhang Y. Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering. Tissue Eng Part A. 2011 Aug; 17(15-16):2123-32.
    View in: PubMed
    Score: 0.007
  209. Hill PS, Apel PJ, Barnwell J, Smith T, Koman LA, Atala A, Van Dyke M. Repair of peripheral nerve defects in rabbits using keratin hydrogel scaffolds. Tissue Eng Part A. 2011 Jun; 17(11-12):1499-505.
    View in: PubMed
    Score: 0.007
  210. Krane LS, Gorbachinsky I, Sirintrapun J, Yoo JJ, Atala A, Hodges SJ. Halofuginone-coated urethral catheters prevent periurethral spongiofibrosis in a rat model of urethral injury. J Endourol. 2011 Jan; 25(1):107-12.
    View in: PubMed
    Score: 0.007
  211. Wu S, Liu Y, Bharadwaj S, Atala A, Zhang Y. Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering. Biomaterials. 2011 Feb; 32(5):1317-26.
    View in: PubMed
    Score: 0.007
  212. Ladd MR, Lee SJ, Atala A, Yoo JJ. Bioreactor maintained living skin matrix. Tissue Eng Part A. 2009 Apr; 15(4):861-8.
    View in: PubMed
    Score: 0.006
  213. Carraro G, Perin L, Sedrakyan S, Giuliani S, Tiozzo C, Lee J, Turcatel G, De Langhe SP, Driscoll B, Bellusci S, Minoo P, Atala A, De Filippo RE, Warburton D. Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells. 2008 Nov; 26(11):2902-11.
    View in: PubMed
    Score: 0.006
  214. Aboushwareb T, Egydio F, Straker L, Gyabaah K, Atala A, Yoo JJ. Erythropoietin producing cells for potential cell therapy. World J Urol. 2008 Aug; 26(4):295-300.
    View in: PubMed
    Score: 0.006
  215. Raya-Rivera AM, Baez C, Atala A, Yoo JJ. Tissue engineered testicular prostheses with prolonged testosterone release. World J Urol. 2008 Aug; 26(4):351-8.
    View in: PubMed
    Score: 0.006
  216. Delo DM, Eberli D, Williams JK, Andersson KE, Atala A, Soker S. Angiogenic gene modification of skeletal muscle cells to compensate for ageing-induced decline in bioengineered functional muscle tissue. BJU Int. 2008 Sep; 102(7):878-84.
    View in: PubMed
    Score: 0.006
  217. Sierpinski P, Garrett J, Ma J, Apel P, Klorig D, Smith T, Koman LA, Atala A, Van Dyke M. The use of keratin biomaterials derived from human hair for the promotion of rapid regeneration of peripheral nerves. Biomaterials. 2008 Jan; 29(1):118-28.
    View in: PubMed
    Score: 0.006
  218. Halum SL, Naidu M, Delo DM, Atala A, Hingtgen CM. Injection of autologous muscle stem cells (myoblasts) for the treatment of vocal fold paralysis: a pilot study. Laryngoscope. 2007 May; 117(5):917-22.
    View in: PubMed
    Score: 0.006
  219. Alukal JP, Zurakowski D, Atala A, Bauer SB, Borer JG, Cilento BG, Mandell J, Peters CA, Paltiel HJ, Retik AB, Diamond DA. Testicular hypotrophy does not correlate with grade of adolescent varicocele. J Urol. 2005 Dec; 174(6):2367-70, discussion 2370.
    View in: PubMed
    Score: 0.005
  220. Borer JG, Gargollo PC, Kinnamon DD, Bauer SB, Khoshbin S, Hendren WH, Peters CA, Diamond DA, Atala A, Chin S, Retik AB. Bladder growth and development after complete primary repair of bladder exstrophy in the newborn with comparison to staged approach. J Urol. 2005 Oct; 174(4 Pt 2):1553-7; discussion 1557-8.
    View in: PubMed
    Score: 0.005
  221. Gargollo PC, Borer JG, Retik AB, Peters CA, Diamond DA, Atala A, Barnewolt CE. Magnetic resonance imaging of pelvic musculoskeletal and genitourinary anatomy in patients before and after complete primary repair of bladder exstrophy. J Urol. 2005 Oct; 174(4 Pt 2):1559-66; discussion 1566.
    View in: PubMed
    Score: 0.005
  222. Borer JG, Gargollo PC, Hendren WH, Diamond DA, Peters CA, Atala A, Grant R, Retik AB. Early outcome following complete primary repair of bladder exstrophy in the newborn. J Urol. 2005 Oct; 174(4 Pt 2):1674-8; discussion 1678-9.
    View in: PubMed
    Score: 0.005
  223. Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, Atala A, Mukhopadhyay D, Soker S. Antiangiogenic properties of gold nanoparticles. Clin Cancer Res. 2005 May 01; 11(9):3530-4.
    View in: PubMed
    Score: 0.005
  224. Diamond DA, Zurakowski D, Atala A, Bauer SB, Borer JG, Cilento BG, Paltiel H, Peters CA, Retik AB. Is adolescent varicocele a progressive disease process? J Urol. 2004 Oct; 172(4 Pt 2):1746-8; discussion 1748.
    View in: PubMed
    Score: 0.005
  225. McLellan DL, Gaston MV, Diamond DA, Lebowitz RL, Mandell J, Atala A, Bauer SB. Anterior urethral valves and diverticula in children: a result of ruptured Cowper's duct cyst? BJU Int. 2004 Aug; 94(3):375-8.
    View in: PubMed
    Score: 0.005
  226. McLellan DL, Retik AB, Bauer SB, Diamond DA, Atala A, Mandell J, Lebowitz RL, Borer JG, Peters CA. Rate and predictors of spontaneous resolution of prenatally diagnosed primary nonrefluxing megaureter. J Urol. 2002 Nov; 168(5):2177-80; discussion 2180.
    View in: PubMed
    Score: 0.004
  227. Smith RC, Machluf M, Bromley P, Atala A, Walsh K. Spatial and temporal control of transgene expression through ultrasound-mediated induction of the heat shock protein 70B promoter in vivo. Hum Gene Ther. 2002 Apr 10; 13(6):697-706.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.